Data from 4 studies showed that patients on chronic HD developed higher levels of anti-SARS-CoV-2 antibodies compared to KTRs though the difference did not reach statistical significance [LIAISON assay – 467 ± 434 AU/mL vs. 32 ± 77 AU/mL, p = 0.053; ABBOTT assay – 1907 ± 2741 AU/mL vs. 65 ± 233 AU/mL, p = 0.189].
← all excerpts
Immunogenicity and Safety of COVID-19 Vaccines in Patients Receiving Renal Replacement Therapy: A Systematic Review and Meta-Analysis.
1
0.0530
0.0530